▁Chron 9.2890625
ic 0.54736328125
▁pain 2.765625
▁is 1.1640625
▁still 6.71875
▁considered 3.990234375
▁to 1.9228515625
▁be 0.03277587890625
▁an 2.6796875
▁extreme 7.265625
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.156005859375
▁ 0.390380859375
8 3.474609375
% 2.189453125
▁of 0.12237548828125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.32080078125
▁countries 0.91796875
. 0.63671875
▁The 2.119140625
▁introduction 7.75390625
▁of 0.0309906005859375
▁the 2.359375
▁study 7.3203125
▁describes 7.28125
▁the 0.57568359375
▁apparent 8.9140625
▁link 4.6875
▁between 0.2440185546875
▁pain 2.71484375
▁and 0.294921875
▁dem 7.14453125
oral 3.392578125
ization 0.1217041015625
. 1.046875
▁Chron 4.515625
ic 0.0032444000244140625
▁pain 0.11016845703125
▁is 1.0947265625
▁always 5.60546875
▁accompanied 2.984375
▁by 0.1500244140625
▁emot 3.390625
ional 0.058197021484375
▁negative 8.1484375
▁experiences 3.111328125
▁and 2.142578125
▁blocks 10.71875
▁a 3.3984375
▁person 0.69384765625
’ 0.86669921875
s 0.00104522705078125
▁ability 1.55078125
▁to 0.0372314453125
▁receive 6.60546875
▁joy 3.634765625
▁and 1.37109375
▁satisfaction 3.314453125
▁from 0.88330078125
▁life 0.767578125
. 0.2147216796875
▁The 1.6474609375
▁research 2.716796875
▁investig 5.42578125
ates 0.380615234375
▁the 0.38623046875
▁development 6.140625
▁of 0.1490478515625
▁de 3.91796875
pression 0.44970703125
▁and 1.3896484375
▁anx 1.703125
iety 0.0011816024780273438
▁among 1.61328125
▁patients 1.447265625
▁receiving 5.83984375
▁ph 5.46484375
arma 3.171875
ce 0.013031005859375
ut 6.0439109802246094e-05
ical 0.006145477294921875
▁op 4.62890625
io 0.10406494140625
ids 0.446044921875
▁and 2.482421875
▁medical 4.05859375
▁mar 1.796875
iju 0.0010929107666015625
ana 5.14984130859375e-05
▁( 2.951171875
MM 1.3515625
) 2.84765625
▁as 2.423828125
▁severe 9.9609375
▁pain 0.80078125
kill 2.70703125
ers 0.0005512237548828125
. 0.224609375
▁It 3.259765625
▁comp 5.015625
ares 0.008514404296875
▁the 0.59912109375
▁effic 4.3515625
acy 0.0019969940185546875
▁of 0.2081298828125
▁pres 6.09765625
cri 1.8583984375
ptions 1.439453125
▁and 1.9482421875
▁exam 4.53125
ines 0.01091766357421875
▁the 0.469482421875
▁possibility 3.927734375
▁of 0.126220703125
▁post 8.203125
- 0.607421875
tre 1.97265625
at 0.0018329620361328125
ment 0.005035400390625
▁de 1.703125
pression 0.082763671875
. 1.4169921875
<0x0A> 0.8115234375
There 4.65234375
▁is 1.1962890625
▁currently 5.52734375
▁a 1.072265625
▁severe 4.9765625
▁lack 1.892578125
▁of 0.01520538330078125
▁information 2.275390625
▁about 1.1533203125
▁the 0.47265625
▁effects 3.1328125
▁of 0.06390380859375
▁op 3.076171875
i 3.697265625
ates 0.01245880126953125
. 3.359375
▁They 4.53125
▁manage 8.40625
▁pain 3.38671875
▁successfully 5.83984375
, 0.97509765625
▁but 0.2374267578125
▁the 2.4921875
▁past 9.03125
▁few 2.27734375
▁dec 1.271484375
ades 0.0005602836608886719
▁indicated 7.02734375
▁the 1.73046875
▁growing 3.609375
▁concern 3.451171875
▁regarding 2.759765625
▁op 2.564453125
iate 1.09375
▁ab 1.5927734375
use 0.0159149169921875
▁in 3.818359375
▁forms 8.8359375
▁of 0.2496337890625
▁over 3.287109375
d 0.10662841796875
ose 0.319580078125
▁and 0.70849609375
▁add 0.71630859375
iction 0.0202789306640625
. 0.1409912109375
▁A 4.03125
▁more 4.7890625
▁manage 7.94140625
able 0.0005698204040527344
▁and 2.10546875
▁sa 2.08984375
fer 0.0001499652862548828
▁alternative 1.330078125
▁might 5.09375
▁be 0.11767578125
▁medical 1.5693359375
▁mar 0.1549072265625
iju 0.0007181167602539062
ana 9.953975677490234e-05
. 0.95751953125
▁However 3.349609375
, 0.00284576416015625
▁the 1.693359375
▁legal 3.958984375
▁status 1.1669921875
▁and 3.1171875
▁novel 9.8515625
ty 0.1324462890625
▁of 0.1492919921875
▁this 2.322265625
▁drug 1.38671875
▁do 4.35546875
▁not 0.012542724609375
▁allow 0.70361328125
▁finding 6.9140625
▁a 2.392578125
▁large 2.5546875
▁number 0.79296875
▁of 0.002201080322265625
▁studies 1.2958984375
▁on 1.7783203125
▁its 0.8134765625
▁effect 2.37109375
iveness 0.18212890625
. 0.64892578125
▁Specifically 8.9453125
, 0.048828125
▁it 2.626953125
▁concerns 5.0234375
▁the 0.81884765625
▁emot 6.49609375
ional 0.015716552734375
▁condition 4.4765625
▁of 0.2169189453125
▁patients 0.67724609375
▁experien 5.3203125
cing 1.9788742065429688e-05
▁chron 0.822265625
ic 0.000392913818359375
▁pain 0.053619384765625
. 0.436767578125
▁This 2.904296875
▁research 1.8681640625
▁paper 4.0625
▁a 1.8388671875
ims 0.0005364418029785156
▁to 0.11566162109375
▁analyze 3.287109375
▁levels 9.9375
▁of 0.021209716796875
▁de 0.481201171875
pression 0.0232391357421875
▁and 0.1824951171875
▁anx 0.0245208740234375
iety 0.0004429817199707031
▁among 0.74755859375
▁people 2.50390625
▁receiving 2.23828125
▁ther 6.609375
apy 0.10675048828125
▁by 4.50390625
▁comparing 8.921875
▁the 1.5380859375
▁effects 2.162109375
▁ph 9.3828125
arma 0.0283660888671875
ce 0.00525665283203125
ut 0.0001049041748046875
ical 0.0034389495849609375
▁of 10.7890625
▁op 0.106689453125
io 0.78076171875
ids 0.054962158203125
▁and 0.23291015625
▁MM 0.369384765625
. 0.2301025390625
<0x0A> 0.44287109375
The 0.751953125
▁study 1.7333984375
▁was 2.373046875
▁conducted 0.6572265625
▁in 1.25
▁the 1.3662109375
▁form 2.599609375
▁of 0.002857208251953125
▁collection 11.4765625
▁and 0.703125
▁analysis 0.39697265625
▁of 0.01129913330078125
▁statistical 3.728515625
▁data 0.1268310546875
. 0.89208984375
▁Part 5.21875
icip 0.2484130859375
ants 0.065673828125
▁were 0.69775390625
▁rec 3.619140625
ru 0.0009851455688476562
ited 0.00020825862884521484
▁for 4.07421875
▁six 6.84375
▁months 0.46337890625
▁at 3.7578125
▁two 2.59375
▁major 3.921875
▁pain 2.751953125
▁relief 4.06640625
▁cent 0.85205078125
ers 0.027740478515625
▁in 0.666015625
▁Israel 5.6328125
. 0.31982421875
▁The 1.2099609375
▁research 2.4140625
ers 1.3798828125
▁used 2.2265625
▁The 7.19140625
▁De 2.9765625
pression 0.023834228515625
▁Module 6.7109375
▁of 0.7373046875
▁the 0.229736328125
▁Pat 3.322265625
ient 0.00949859619140625
▁Health 0.0330810546875
▁Question 0.019866943359375
naire 0.026092529296875
▁and 2.748046875
▁the 0.8212890625
▁General 1.21875
ized 0.611328125
▁An 0.0054168701171875
x 0.0001074075698852539
iety 0.0004355907440185547
▁Dis 0.182373046875
order 0.021240234375
▁Sc 1.47265625
ale 0.00286865234375
▁to 0.95458984375
▁interview 7.56640625
▁participants 2.697265625
, 4.390625
▁evaluate 4.5546875
▁their 0.55908203125
▁answers 4.24609375
, 0.357666015625
▁and 0.037109375
▁conduct 4.984375
▁the 1.8271484375
▁study 2.435546875
. 0.1019287109375
▁To 4.7890625
▁specifically 9.9140625
▁evaluate 3.25390625
▁compare 13.0859375
▁and 3.771484375
▁the 5.55859375
▁prob 9.71875
abilities 0.1517333984375
▁of 0.1446533203125
▁de 1.0771484375
pression 0.039398193359375
▁or 4.0859375
▁anx 0.047576904296875
iety 0.0008988380432128906
▁among 1.703125
▁the 2.18359375
▁diverse 9.5703125
▁groups 0.880859375
, 0.79638671875
▁the 0.44384765625
▁study 2.728515625
▁used 1.30078125
▁multiple 5.4609375
▁log 0.72607421875
istic 0.029937744140625
▁regression 0.28369140625
▁analysis 1.34375
▁and 2.716796875
▁chose 8.7578125
▁medical 6.14453125
▁mar 0.083740234375
iju 0.0013952255249023438
ana 7.283687591552734e-05
▁as 0.58056640625
▁the 0.89501953125
▁control 2.841796875
▁group 0.615234375
. 0.271240234375
<0x0A> 0.423583984375
This 4.1171875
▁type 6.28515625
▁study 9.1953125
▁of 4.7890625
▁is 4.65625
▁the 3.375
▁most 2.427734375
▁reve 7.76171875
aling 0.0020656585693359375
▁and 1.91796875
▁inclus 7.0625
ive 0.0014810562133789062
, 3.521484375
▁as 1.37890625
▁it 0.3408203125
▁direct 9.2109375
▁contains 11.65625
▁responses 7.11328125
▁from 0.79296875
▁a 2.12890625
▁large 1.0439453125
▁number 0.55810546875
▁of 0.01262664794921875
▁participants 1.177734375
. 0.84326171875
▁All 5.19140625
▁tools 8.6640625
▁in 5.6640625
▁the 0.7734375
▁form 4.12890625
▁of 0.038238525390625
▁question 0.70166015625
na 0.0274200439453125
ires 0.0005893707275390625
▁and 1.248046875
▁scales 2.66796875
▁have 3.4296875
▁already 3.919921875
▁been 0.411376953125
▁used 2.357421875
▁and 1.8173828125
▁their 4.91796875
▁proved 9.015625
▁effic 3.443359375
acy 0.0064697265625
▁for 3.97265625
▁collect 3.791015625
ing 0.005573272705078125
▁analyt 7.23828125
ical 0.131591796875
▁data 0.19677734375
. 0.434814453125
▁It 3.361328125
▁helps 4.171875
▁to 0.59375
▁system 6.9296875
at 0.72412109375
ize 0.005489349365234375
▁and 1.400390625
▁class 4.6875
ify 0.005130767822265625
▁distinct 8.328125
▁kinds 6.296875
▁of 0.01788330078125
▁information 2.408203125
▁for 4.1171875
▁subsequent 5.08203125
▁un 8.5
comp 4.31640625
licated 0.0204010009765625
▁services 12.296875
. 0.52880859375
▁Thus 4.90625
, 0.0136566162109375
▁research 4.484375
ers 0.277099609375
▁can 1.791015625
▁compare 2.7734375
▁the 1.1162109375
▁effects 2.80078125
▁of 0.1212158203125
▁medic 3.6484375
ations 0.6943359375
▁on 1.744140625
▁patients 2.05078125
▁of 3.982421875
▁diverse 3.1796875
▁age 1.9296875
▁groups 2.265625
, 0.72900390625
▁background 3.9609375
s 0.162841796875
, 0.041107177734375
▁physical 5.57421875
▁conditions 1.3388671875
, 0.07098388671875
▁emot 6.21875
ional 0.0262298583984375
▁states 1.408203125
, 0.08416748046875
▁and 0.39306640625
▁so 2.599609375
▁on 0.231201171875
. 0.0687255859375
<0x0A> 0.8291015625
The 0.7119140625
▁analysis 3.9609375
▁of 0.73291015625
▁any 9.5703125
▁human 6.99609375
▁reaction 4.38671875
▁has 4.7265625
▁a 1.751953125
▁high 3.125
▁potential 3.19140625
▁of 1.6796875
▁subject 2.76953125
iveness 3.44921875
▁and 1.2802734375
▁bias 1.865234375
, 2.1328125
▁especially 2.380859375
▁regarding 4.02734375
▁people 5.01171875
▁in 3.748046875
▁severe 2.69921875
▁pain 0.66357421875
▁and 2.25
▁un 5.68359375
stable 0.98095703125
▁emot 0.630859375
ional 0.0745849609375
▁condition 2.296875
. 0.0556640625
▁Perhaps 8.1953125
▁some 5.01171875
▁patients 1.98828125
▁tend 4.89453125
▁to 0.01340484619140625
▁ex 2.064453125
agger 0.010772705078125
ate 0.003063201904296875
▁their 0.94189453125
▁de 3.126953125
press 1.880859375
ive 0.078125
▁state 2.525390625
▁or 1.6591796875
▁vice 5.6171875
▁vers 0.041839599609375
a 8.046627044677734e-05
, 1.1806640625
▁de 7.48046875
- 2.666015625
emph 0.4736328125
as 0.004230499267578125
ize 0.07025146484375
▁serious 6.6875
▁difficulties 5.61328125
. 0.82861328125
▁Because 6.38671875
▁the 2.591796875
▁survey 4.81640625
▁responses 6.8671875
▁were 1.458984375
▁thoroughly 8.6953125
▁anonymous 2.728515625
, 0.270263671875
▁the 1.203125
▁research 1.0185546875
ers 0.1998291015625
▁were 2.513671875
▁unable 2.869140625
▁to 0.0033111572265625
▁carefully 7.609375
▁analyze 2.8046875
▁each 2.509765625
▁patient 2.576171875
’ 0.61572265625
s 0.0015363693237304688
▁reaction 4.125
▁and 1.3427734375
▁compare 3.69921875
▁it 0.8173828125
▁to 0.630859375
▁the 0.95849609375
▁actual 4.29296875
▁states 7.5390625
▁of 0.74169921875
▁condition 6.81640625
. 0.32421875
▁More 6.30078125
▁accurate 3.208984375
▁answers 4.5625
▁could 1.861328125
▁be 0.75537109375
▁obtained 1.05078125
▁by 1.4443359375
▁professional 5.921875
▁psych 1.130859375
olog 0.394287109375
ists 0.001873016357421875
▁via 7.2109375
▁personal 2.52734375
▁communication 4.24609375
▁and 1.947265625
▁behavior 6.28515625
al 0.268310546875
▁analysis 2.115234375
. 0.250244140625
▁However 2.8984375
, 0.0013179779052734375
▁this 1.4111328125
▁method 2.310546875
▁of 2.462890625
▁research 1.85546875
▁is 1.1669921875
▁way 5.84375
▁more 0.91259765625
▁resource 4.640625
- 0.37646484375
int 1.4013671875
ensive 0.03350830078125
▁and 0.3984375
▁energy 10.5859375
- 0.12054443359375
consum 0.37939453125
ing 0.002635955810546875
. 0.6982421875
<0x0A> 0.425048828125
Part 6.0234375
icip 0.1785888671875
ants 0.14453125
▁were 1.3486328125
▁rec 1.93359375
ru 0.0007872581481933594
ited 8.106231689453125e-06
▁for 1.7568359375
▁six 0.32470703125
▁months 0.008392333984375
▁at 0.345703125
▁two 0.067626953125
▁major 0.079345703125
▁pain 0.0384521484375
▁relief 0.01983642578125
▁cent 0.0137481689453125
ers 0.0011682510375976562
▁in 0.041351318359375
▁Israel 0.010101318359375
. 0.179931640625
▁All 4.48046875
▁patients 1.8251953125
▁experienced 4.23828125
▁chron 0.79638671875
ic 0.0002751350402832031
▁pain 0.1649169921875
▁for 2.5
▁at 0.677734375
▁least 0.0031070709228515625
▁ 1.7548828125
3 1.5244140625
▁months 0.252197265625
. 1.1953125
▁The 1.4033203125
▁study 1.65625
▁included 1.697265625
▁ 0.57421875
8 2.970703125
9 2.484375
0 2.923828125
▁participants 1.6904296875
, 1.3828125
▁of 2.71484375
▁which 0.4638671875
▁ 0.099365234375
4 1.2216796875
7 2.578125
4 2.59765625
▁( 2.923828125
5 0.09259033203125
9 4.765625
%) 0.75048828125
▁were 0.830078125
▁treated 3.03515625
▁sole 6.8359375
ly 0.0005207061767578125
▁with 0.31982421875
▁op 1.0166015625
io 0.248779296875
ids 0.12744140625
, 0.6279296875
▁ 0.6708984375
3 1.21875
2 2.2578125
9 2.46484375
▁( 0.050323486328125
4 2.494140625
1 1.3134765625
%) 0.05712890625
▁were 1.4970703125
▁treated 0.52392578125
▁with 0.432861328125
▁MM 0.7666015625
, 0.42138671875
▁and 0.11761474609375
▁ 0.2103271484375
7 1.9599609375
7 2.3828125
▁( 0.1163330078125
8 1.8759765625
. 0.943359375
6 2.357421875
%) 0.0677490234375
▁acquired 10.4453125
▁both 0.60302734375
▁( 4.87890625
Fe 9.0078125
ing 1.2763671875
old 0.3896484375
▁et 1.03125
▁al 0.022186279296875
., 0.1690673828125
▁ 0.01532745361328125
2 0.00681304931640625
0 0.00035262107849121094
1 0.195068359375
7 1.5908203125
). 0.061431884765625
▁The 1.193359375
▁remaining 7.5078125
▁ten 6.69921875
▁participants 1.384765625
▁who 4.86328125
▁did 2.1953125
▁not 0.0094757080078125
▁receive 2.193359375
▁ph 3.755859375
arma 0.1258544921875
ce 0.0009851455688476562
ut 2.6226043701171875e-06
ical 0.0029125213623046875
▁op 2.736328125
io 0.1173095703125
ids 0.040252685546875
▁and 2.509765625
▁medical 1.728515625
▁mar 0.0411376953125
iju 0.0004868507385253906
ana 6.759166717529297e-05
▁were 0.473388671875
▁with 6.7578125
dra 0.0830078125
wn 5.817413330078125e-05
▁from 0.2230224609375
▁the 0.190185546875
▁analysis 2.271484375
▁in 4.97265625
▁the 1.1484375
▁research 4.2265625
. 1.0478515625
▁Therefore 5.17578125
, 0.01482391357421875
▁it 3.900390625
▁is 1.3466796875
▁not 2.939453125
▁possible 0.681640625
▁to 0.00742340087890625
▁compreh 5.98046875
ens 0.138916015625
ively 0.0204620361328125
▁compare 1.408203125
▁patients 4.890625
▁taking 3.830078125
▁medic 4.12109375
ations 0.5390625
▁with 1.4296875
▁those 0.96240234375
▁do 7.75
▁who 8.921875
▁not 0.80029296875
. 0.66357421875
<0x0A> 0.57958984375
The 0.83544921875
▁study 1.671875
▁conducted 4.2734375
▁a 1.8876953125
▁correlation 6.421875
▁type 9.1328125
▁of 0.9033203125
▁research 0.88330078125
▁with 3.55859375
▁variable 8.4296875
▁measures 5.203125
. 0.9287109375
▁evaluated 16.171875
▁It 8.0859375
▁the 3.12890625
▁inter 6.1328125
dep 2.6171875
end 0.0011005401611328125
ence 0.016876220703125
▁of 0.7509765625
▁various 3.59375
▁factors 1.0693359375
▁that 3.005859375
▁affected 4.11328125
▁the 0.49072265625
▁physical 6.1015625
▁emot 6.7421875
ional 0.00775909423828125
▁and 1.537109375
▁condition 5.109375
▁of 0.372802734375
▁patients 0.8701171875
▁experien 3.4140625
cing 8.380413055419922e-05
▁chron 0.2474365234375
ic 0.0005269050598144531
▁pain 0.03082275390625
. 0.1429443359375
▁For 4.27734375
▁example 1.1103515625
, 0.00450897216796875
▁the 1.0068359375
▁survey 5.53515625
▁showed 4.06640625
▁that 0.4150390625
▁the 1.91796875
▁ratio 6.45703125
▁of 0.1083984375
▁female 3.546875
▁patients 0.93603515625
▁was 1.3203125
▁remark 8.046875
ably 0.0004551410675048828
▁higher 0.2069091796875
▁in 2.29296875
▁the 0.43994140625
▁op 3.76953125
i 3.404296875
ates 0.01407623291015625
▁group 0.266357421875
▁compared 2.560546875
▁to 0.06463623046875
▁the 0.630859375
▁MM 0.1917724609375
▁group 0.366455078125
. 0.493408203125
▁In 3.412109375
▁turn 3.69921875
, 0.004608154296875
▁people 4.8828125
▁on 4.6015625
▁op 2.984375
i 0.71044921875
ates 0.005016326904296875
▁were 0.97607421875
▁more 1.3603515625
▁likely 0.322998046875
▁to 0.0341796875
▁report 2.830078125
▁major 5.94140625
▁de 0.4951171875
press 0.6953125
ive 0.0034923553466796875
▁dis 0.9453125
orders 1.6640625
. 1.669921875
<0x0A> 2.107421875
The 0.8828125
▁question 5.578125
na 0.8359375
ires 0.0001404285430908203
▁used 2.015625
▁different 7.83984375
▁variable 8.4375
▁measures 0.6376953125
▁to 1.662109375
▁collect 2.54296875
▁information 1.4697265625
. 1.3154296875
▁For 1.751953125
▁example 0.2449951171875
, 0.0028400421142578125
▁it 4.26953125
▁included 2.00390625
▁compreh 8.265625
ensive 0.0433349609375
▁so 5.56640625
cio 0.005306243896484375
- 0.258056640625
dem 0.12017822265625
ographic 0.0771484375
▁data 0.98974609375
: 4.87890625
▁gender 2.037109375
, 0.051361083984375
▁age 0.280029296875
, 0.038818359375
▁country 4.3125
, 2.71484375
▁type 4.359375
▁of 0.07763671875
▁residence 3.892578125
▁( 2.712890625
urban 0.7802734375
/ 1.3583984375
r 0.1600341796875
ural 0.0010080337524414062
), 0.2078857421875
▁years 6.1953125
▁of 0.1805419921875
▁education 0.69287109375
, 0.1082763671875
▁and 1.43359375
▁employ 2.470703125
ment 0.001888275146484375
▁status 0.68798828125
. 0.15771484375
▁Pat 4.546875
ients 0.087158203125
▁were 1.15234375
▁asked 1.5517578125
▁also 6.55859375
▁about 1.0078125
▁their 0.74169921875
▁medical 2.521484375
▁history 0.63134765625
▁over 8.71875
▁the 0.08251953125
▁years 4.625
▁and 1.697265625
▁the 1.5341796875
▁current 2.91796875
▁presence 5.0
▁of 0.09881591796875
▁any 2.24609375
▁severe 3.822265625
▁dise 1.8583984375
ases 0.00018990039825439453
▁such 4.3125
▁as 0.007175445556640625
▁heart 2.595703125
▁failure 1.693359375
, 0.320556640625
▁di 1.5615234375
ab 0.0008702278137207031
etes 0.00246429443359375
, 0.08807373046875
▁ar 4.0859375
th 0.1612548828125
rit 0.0267791748046875
is 0.0052490234375
, 0.048126220703125
▁and 1.1865234375
▁so 0.7734375
▁on 0.049346923828125
. 0.044281005859375
▁The 1.673828125
▁third 6.9921875
▁measure 3.83984375
▁of 2.451171875
▁the 0.70654296875
▁question 1.7587890625
naire 0.3369140625
▁was 1.1884765625
▁indicated 10.484375
▁by 1.6572265625
▁information 6.71484375
▁on 2.05859375
▁any 5.69921875
▁twelve 14.171875
- 0.249755859375
month 0.14794921875
▁and 4.94921875
▁lifetime 0.76416015625
▁drug 3.404296875
▁and 1.6435546875
▁alco 0.1444091796875
hol 0.00016260147094726562
▁consumption 4.578125
. 0.426513671875
▁In 3.515625
▁addition 0.986328125
, 0.1536865234375
▁the 0.97705078125
▁record 10.1953125
▁included 1.34375
▁a 2.78125
▁pain 4.68359375
▁measurement 5.01953125
▁scale 0.8583984375
▁from 4.25390625
▁ 0.50439453125
0 0.296875
▁to 0.24755859375
▁ 0.008880615234375
1 0.07110595703125
0 0.035491943359375
▁to 3.37890625
▁evaluate 1.6005859375
▁dis 5.8046875
com 0.1229248046875
fort 0.001529693603515625
▁feelings 7.94921875
▁during 4.11328125
▁the 0.307373046875
▁last 1.111328125
▁month 1.728515625
. 0.2105712890625
<0x0A> 0.41552734375
Am 6.0
ong 0.0059814453125
▁all 2.365234375
▁participants 2.017578125
▁in 3.5234375
▁the 0.179443359375
▁study 0.5126953125
, 0.06500244140625
▁ 0.8408203125
4 1.818359375
2 2.490234375
. 1.07421875
2 2.224609375
% 0.06512451171875
▁suffered 3.6953125
▁from 0.067626953125
▁de 1.591796875
pression 0.254150390625
, 1.0078125
▁and 1.2548828125
▁ 0.1484375
3 1.4248046875
7 2.3671875
% 2.59765625
▁experienced 2.2734375
▁excess 7.125
ive 0.0293426513671875
▁anx 0.237060546875
iety 0.0023326873779296875
. 0.35888671875
▁The 1.419921875
▁pl 10.703125
ur 0.568359375
ality 0.0009474754333496094
▁of 0.1131591796875
▁de 2.521484375
press 1.2958984375
ive 0.034576416015625
▁dis 2.53515625
orders 0.08807373046875
▁among 3.05859375
▁patients 1.021484375
▁in 2.837890625
▁the 0.31005859375
▁op 0.56689453125
i 0.4375
ates 0.0020198822021484375
, 8.2734375
▁medical 4.3828125
▁mar 0.040130615234375
iju 0.0010156631469726562
ana 5.8770179748535156e-05
, 0.414794921875
▁and 0.10491943359375
▁mixed 1.5888671875
▁OP 11.1171875
MM 4.0078125
▁groups 0.607421875
▁number 8.828125
ed 0.02838134765625
▁ 0.19189453125
5 1.6123046875
7 2.646484375
. 0.50732421875
1 2.498046875
%, 0.2064208984375
▁ 0.0045166015625
2 2.130859375
2 2.6484375
. 0.1036376953125
3 2.2734375
%, 0.07537841796875
▁and 0.06170654296875
▁ 0.00296783447265625
5 1.9638671875
1 2.056640625
. 0.1507568359375
4 1.884765625
%, 0.2061767578125
▁respectively 0.0264892578125
. 0.210205078125
▁The 1.2841796875
▁pl 3.892578125
ur 0.01027679443359375
ality 3.707408905029297e-05
▁of 0.031829833984375
▁anx 0.444580078125
iety 0.020355224609375
▁contained 10.5546875
▁ 0.322509765625
4 1.1181640625
8 2.353515625
. 0.1693115234375
4 2.19921875
% 1.9345703125
▁among 2.708984375
▁OP 5.24609375
▁patients 6.015625
, 0.28662109375
▁ 0.08746337890625
2 0.943359375
1 2.4765625
. 0.10992431640625
5 2.1171875
% 0.032623291015625
▁among 0.47802734375
▁MM 0.11749267578125
▁patients 0.371826171875
, 0.03509521484375
▁and 0.0182647705078125
▁ 0.0275726318359375
3 1.376953125
8 1.9052734375
. 0.12548828125
7 2.220703125
% 0.0185089111328125
▁among 0.215087890625
▁OP 2.05859375
MM 0.1488037109375
▁participants 3.1171875
. 0.2132568359375
▁Pat 5.1015625
ients 0.019012451171875
▁who 1.916015625
▁took 2.25
▁strong 9.9140625
▁op 0.6806640625
i 0.7734375
ates 0.0031528472900390625
▁were 1.1962890625
▁t 9.9765625
ended 0.70654296875
▁to 0.0190887451171875
▁place 9.7890625
▁their 2.0625
▁pain 1.2041015625
▁on 1.9267578125
▁a 0.65673828125
▁scale 1.7080078125
▁of 0.426025390625
▁ 0.10662841796875
9 2.484375
▁to 2.271484375
▁ 0.0156707763671875
1 0.006397247314453125
0 0.00737762451171875
▁( 2.759765625
Fe 1.8056640625
ing 0.0038471221923828125
old 0.0006532669067382812
▁et 0.0148773193359375
▁al 0.0029621124267578125
., 0.01326751708984375
▁ 0.0029888153076171875
2 0.00036144256591796875
0 5.221366882324219e-05
1 0.001277923583984375
7 0.00708770751953125
). 0.0124969482421875
▁They 4.58203125
▁were 1.69921875
▁also 0.89208984375
▁an 9.4609375
gu 4.47265625
ished 0.11920166015625
▁em 6.11328125
otion 0.002471923828125
ally 0.0018682479858398438
▁and 0.98974609375
▁react 7.6171875
ed 0.0310821533203125
▁rad 9.3515625
ically 0.0018033981323242188
▁neg 4.5078125
atively 0.0020389556884765625
▁to 0.1842041015625
▁almost 5.4921875
▁all 1.4716796875
▁survey 3.7890625
▁questions 0.25048828125
. 0.30517578125
▁Pat 3.85546875
ients 0.00513458251953125
▁who 1.2392578125
▁took 1.6669921875
▁only 4.2265625
▁MM 0.369384765625
▁or 2.849609375
▁mixed 2.34375
▁medic 1.373046875
ations 0.22900390625
▁course 13.1953125
▁had 2.681640625
▁a 1.45703125
▁significantly 2.890625
▁more 3.2265625
▁stable 2.478515625
▁emot 0.8701171875
ional 0.0018663406372070312
▁state 0.65869140625
▁and 1.05859375
▁cop 6.65234375
ed 0.026641845703125
▁with 0.371337890625
▁pain 0.86962890625
▁more 1.88671875
▁manage 6.9375
able 1.1083984375
. 0.26513671875
<0x0A> 0.25048828125
One 5.09765625
▁of 0.2154541015625
▁the 0.007289886474609375
▁major 2.607421875
▁limitations 2.42578125
▁is 3.0078125
▁the 0.5244140625
▁ins 4.671875
u 0.06756591796875
fficient 0.059356689453125
ly 3.369140625
▁high 3.193359375
▁response 3.41015625
▁rate 0.11810302734375
, 2.689453125
▁ 4.5
5 1.62109375
7 2.876953125
% 2.251953125
▁instead 6.58984375
▁of 0.014373779296875
▁ 0.53076171875
7 1.8408203125
0 0.4228515625
% 1.3720703125
▁( 2.615234375
Fe 0.5927734375
ing 0.002376556396484375
old 0.0003991127014160156
▁et 0.009796142578125
▁al 0.0004100799560546875
., 0.0086212158203125
▁ 0.002300262451171875
2 0.0001913309097290039
0 0.0001232624053955078
1 0.0005125999450683594
7 0.004146575927734375
). 0.0126495361328125
▁It 1.8740234375
▁can 3.134765625
▁be 0.80126953125
▁fairly 8.296875
▁explained 1.556640625
▁by 0.2027587890625
▁the 0.27294921875
▁weak 7.41015625
▁focus 7.00390625
▁of 0.6943359375
▁respond 5.66015625
ents 0.1258544921875
▁who 3.451171875
▁have 3.8515625
▁overcome 8.0546875
▁severe 2.05859375
▁pain 0.5771484375
▁sens 7.5703125
ations 0.23046875
▁and 0.88037109375
▁de 4.76953125
press 0.78662109375
ive 0.04840087890625
▁episodes 2.28515625
. 0.51318359375
▁It 2.828125
▁is 0.798828125
▁not 2.501953125
▁clear 3.474609375
▁how 1.89453125
▁to 3.435546875
▁use 5.1015625
▁these 2.9296875
▁statistics 3.86328125
, 3.01171875
▁as 0.68994140625
▁they 1.9326171875
▁still 5.22265625
▁may 4.53515625
▁be 1.3056640625
▁relevant 5.921875
▁for 1.6318359375
▁the 1.8203125
▁overall 4.6328125
▁analysis 2.755859375
. 0.9091796875
